We previously demonstrated that activation of the A2A Adenosine receptor (A2AR) inhibits AMPK through a cAMP/PKA-dependent pathway in experimental models of Huntington's disease (HD) and ALS (Ju et al., 2011; Liu et al., 2015a,b). Here, PRKAA1 is linked to Huntington disease.